Has experience in Morphology, focusing on Cytology and Celular Biology (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Gliosarcoma is a primary malignant tumor and a histopathological variant of wild type glioblastoma multiforme (GBM) isocitrate dehydrogenase (HDI), the rarest and most severe brain tumor. The current standard treatment consists of chemotherapy, radiotherapy and surgical resection of the malignant tissue. However, despite the numerous advances in the techniques, the prognosis remains unfav…
Gliosarcoma is a highly agressive malignant neoplasm that affects the Central Nervous System and accounts for 2% of all brain tumors. Despite the advances in conventional treatment techniques, which consist of surgical removal of the lesion, followed by radiotherapy and chemotherapy as secondary treatments, the prognosis of patients with CNS tumors continues to be unfavorable, making it n…
| 3 / 3 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID